F. Bourdillon, Editorial. 1,6 million de fumeurs en moins en deux ans, des résultats inédits

, Bull Epidémiol Hebd, issue.15, pp.270-271, 2019.

F. Fowkes, V. Aboyans, F. Fowkes, M. M. Mcdermott, U. Sampson et al., Peripheral artery disease: epidemiology and global perspectives, Nat Rev Cardiol. Mars, vol.14, issue.3, pp.156-70, 2017.

V. Aboyans, M. Sevestre, I. Désormais, P. Lacroix, G. Fowkes et al., Epidémiologie de l'artériopathie des membres inférieurs, La Presse Médicale. janv, vol.47, issue.1, pp.38-46, 2018.

G. Marchand, Epidémiologie et facteurs de risque de l'artériopathie oblitérante des membres inférieurs, Annales de Cardiologie et d'Angéiologie, vol.50, issue.2, pp.119-146, 2001.

M. H. Criqui and V. Aboyans, Epidemiology of Peripheral Artery Disease, Circulation Research, vol.116, pp.1509-1526, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01233163

F. Bacourt, D. Foster, and M. E. , Athérosclérose oblitérante des membres inférieurs, EMC -Angéiologie. janv, vol.5, issue.1, pp.1-13, 2010.

D. M. Nathan, D. For-the, and . Group, The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview. Dia Care, janv, vol.37, issue.1, p.916, 2014.

. The-sprint-research and . Group, A Randomized Trial of Intensive versus Standard Blood-Pressure Control, N Engl J Med, vol.373, issue.22, p.210316, 2015.

J. D. Hooi, A. Kester, H. Stoffers, M. M. Overdijk, J. W. Van-ree et al., Incidence of and Risk Factors for Asymptomatic Peripheral Arterial Occlusive Disease: A Longitudinal Study, American Journal of Epidemiology. 1 avr, vol.153, issue.7, pp.666-72, 2001.

D. Xu, L. Zou, Y. Xing, L. Hou, Y. Wei et al., Diagnostic Value of Ankle-Brachial Index in Peripheral Arterial Disease: A Meta-analysis, Canadian Journal of Cardiology. avr, vol.29, issue.4, pp.492-500, 2013.

M. Fowkes, Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis, JAMA. 9 juill, vol.300, issue.2, p.197, 2008.

R. Collins, G. Cranny, J. Burch, R. Aguiar-ibanez, C. D. Wright et al., A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease, Health Technol Assess, vol.11, issue.20, 2007.

R. Met, S. Bipat, D. A. Legemate, J. A. Reekers, and M. Koelemay, Diagnostic Performance of Computed Tomography Angiography in Peripheral Arterial Disease, JAMA, vol.301, issue.4, pp.415-424, 2009.

J. Izaaryene, J. Soussan, J. Gaubert, P. Cassagneau, M. Jolibert et al., Imagerie en coupe dans le diagnostic de la pathologie athéromateuse des vaisseaux des membres inférieurs. EMC -Radiologie et imagerie médicale -Cardiovasculaire -Thoracique -Cervicale, Févr, vol.8, issue.1, pp.1-12, 2013.

F. Fowkes, D. Rudan, I. Rudan, V. Aboyans, J. O. Denenberg et al., Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. The Lancet, vol.382, pp.1329-1369, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00925590

B. Sigvant, F. Lundin, and E. Wahlberg, The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease, European Journal of Vascular and Endovascular Surgery. mars, vol.51, issue.3, pp.395-403, 2016.

G. C. Leng, A. J. Lee, F. Fowkers, M. Whiteman, J. Dunbar et al., Natural History and Cardiovascular Events in Symptomatic and Asymptomatic Peripheral Arterial Disease in the General Population, International Journal of Epidemiology. 1 déc, vol.25, issue.6, pp.1172-81, 1996.

J. P. Cambou, V. Aboyans, J. Constans, P. Lacroix, C. Dentans et al., Characteristics and Outcome of Patients Hospitalised for Lower Extremity Peripheral Artery Disease in France: The COPART Registry, European Journal of Vascular and Endovascular Surgery. mai, vol.39, issue.5, pp.577-85, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00606139

V. Aboyans, J. Ricco, M. Bartelink, M. Björck, M. Brodmann et al., Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collabaroation with the European Society for Vascular Surgery (ESVS), European Heart Journal, pp.39-763, 2018.

J. G. Regensteiner, Exercise in the Treatment of Claudication: Assessment and Treatment of Functional Impairment, Vasc Med. août, vol.2, issue.3, pp.238-280, 1997.

T. P. Murphy, D. E. Cutlip, J. G. Regensteiner, E. R. Mohler, D. J. Cohen et al.,

, Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to

, Aortoiliac Peripheral Artery Disease, Journal of the American College of Cardiology. mars, vol.65, issue.10, pp.999-1009, 2015.

S. Sakamoto, N. Yokoyama, Y. Tamori, K. Akutsu, H. Hashimoto et al., Patients With Peripheral Artery Disease Who Complete 12-Week Supervised Exercise Training Program Show Reduced Cardiovascular Mortality and Morbidity, Circ J, vol.73, issue.1, pp.167-73, 2009.

, Critical Leg Ischaemia Prevention Study (CLIPS) Group. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial, J Intern Med. mars, vol.261, issue.3, pp.276-84, 2007.

M. Gent, D. Beaumont, J. Blanchard, M. G. Bousser, J. Coffman et al., A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). The Lancet, Nov, vol.348, pp.1329-1368, 1996.

W. R. Hiatt, F. Fowkes, G. Heizer, J. S. Berger, I. Baumgartner et al., Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease, N Engl J Med. 5 janv, vol.376, issue.1, p.3240, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02048713

D. A. Morrow, E. Braunwald, M. P. Bonaca, S. F. Ameriso, A. J. Dalby et al.,

, Vorapaxar in the Secondary Prevention of Atherothrombotic Events, N Engl J Med. 12 avr, vol.366, issue.15, p.140413, 2012.

S. S. Anand, F. Caron, J. W. Eikelboom, J. Bosch, L. Dyal et al., Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease, Journal of the American College of Cardiology. mai, vol.71, issue.20, p.230615, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02042850

M. P. Bonaca, R. M. Bauersachs, S. S. Anand, E. S. Debus, M. R. Nehler et al.,

, Rivaroxaban in Peripheral Artery Disease after Revascularization, N Engl J Med, vol.21, issue.2020, pp.1994-2004

. Mrc/bhf, Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial. The Lancet, juill, vol.360, issue.9326, pp.7-22, 2002.

D. J. Kumbhani, S. Phg, C. P. Cannon, K. A. Eagle, S. C. Smith et al., Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry, Eur Heart J, vol.35, issue.41, pp.2864-72, 2014.

F. Mach, C. Baigent, A. L. Catapano, K. C. Koskinas, M. Casula et al., , 2019.

. Esc/eas, Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, European Heart Journal. 1 janv, vol.41, issue.1, pp.111-88, 2020.

M. S. Sabatine, R. P. Giugliano, A. C. Keech, N. Honarpour, S. D. Wiviott et al.,

, Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease, N Engl J Med, vol.376, issue.18, p.171322, 2017.

B. Williams, G. Mancia, E. A. Rosei, M. Azizi, M. Burnier et al., , 2018.

. Esc/esh, Guidelines for the management of arterial hypertension, European Heart Journal, vol.39, pp.3021-3104, 2018.

J. Östergren, P. Sleight, G. Dagenais, K. Danisa, J. Bosch et al., Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

, European Heart Journal. janv, vol.25, issue.1, pp.17-24, 2004.

S. Yusuf, P. Sleight, C. Anderson, K. Teo, I. Copland et al., Ramipril, or Both in Patients at High Risk for Vascular Events, N Engl J Med. 10 avr, vol.358, issue.15, pp.1547-59, 2008.

P. J. Grant, C. J. Bailey, V. Delgado, M. Federici, G. Filippatos et al., ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD, European Heart Journal, pp.0-1, 2019.

S. Singh, E. J. Armstrong, W. Sherif, B. Alvandi, G. G. Westin et al.,

J. R. Laird, Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty, Vasc Med, vol.19, issue.4, pp.307-314, 2014.

M. Takahara, H. Kaneto, O. Iida, S. Gorogawa, N. Katakami et al., The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia, Diabetes Care, vol.33, issue.12, pp.2538-2580, 2010.

A. Bradbury, C. V-ruckley, F. Fowkes, J. Forbes, and . Gillespie, Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial, Lancet, vol.366, pp.1925-1959, 2005.

J. Constans, A. Solanilla, C. Boulon, and C. Conri, Artériopathie oblitérante des membres inférieurs du sujet jeune, La Presse Médicale. janv, vol.39, issue.1, pp.11-17, 2010.

S. Cotard, A. Nouni, V. Jaquinandi, G. Gladu, A. Kaladji et al., Artériopathies périphériques juvéniles. Annales de Cardiologie et d'Angéiologie, Sept, vol.65, issue.4, pp.275-85, 2016.

M. Sauvanier, J. Constans, S. Skopinski, D. Barcat, A. Berard et al., LES ARTERIOPATHIES DES MEMBRES INFERIEURS DEBUTANT AVANT 50 ANS Analyse rétrospective de 73 patients, Journal des Maladies Vasculaires, vol.27, issue.2, pp.69-76, 2002.

J. W. Olin, J. R. Young, R. A. Graor, W. F. Ruschhaupt, and J. R. Bartholomew, The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease), Circulation, vol.82, pp.3-8, 1990.

T. Ohta, H. Ishioashi, M. Hosaka, and I. Sugimoto, Clinical and social consequences of Buerger disease, J Vasc Surg, vol.39, pp.176-180, 2004.

L. Joncour, A. Soudet, S. Dupont, A. Espitia, O. Koskas et al., Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients, J Am Heart Assoc. 4 déc, vol.7, issue.23, p.10677, 2018.

L. T. Cooper, T. S. Tse, M. A. Mikhail, R. D. Mcbane, A. W. Stanson et al., Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease), J Am Coll Cardiol, vol.44, pp.2410-2411, 2004.

M. Sugimoto, H. Miyachi, H. Morimae, A. Kodama, H. Narita et al.,

K. Komori, Fate of ischemic limbs in patients with Buerger's disease based on our 30-year experience: does smoking have a definitive impact on the late loss of limbs, Surg Today, vol.45, pp.466-470, 2015.

R. J. Valentine, M. R. Jackson, J. G. Modrall, K. E. Mcintyre, and G. P. Clagett, The progressive nature of peripheral arterial disease in young adults: A prospective analysis of white men referred to a vascular surgery service, Journal of Vascular Surgery. sept, vol.30, issue.3, pp.436-481, 1999.

P. J. Levy, C. A. Hornung, J. L. Haynes, and D. S. Rush, Lower extremity ischemia in adults younger than forty years of age: A community-wide survey of premature atherosclerotic arterial disease, Journal of Vascular Surgery. Mai, vol.19, issue.5, p.87381, 1994.

P. J. Levy, T. Close, C. A. Hornung, J. L. Haynes, and D. S. Rush, Percutaneous Transluminal Angioplasty in Adults Less Than 45 Years of Age With Premature Lower Extremity Atherosclerosis, Annals of Vascular Surgery. sept, vol.9, issue.5, p.4719, 1995.

W. E. Evans, J. P. Hayes, and B. D. Vermillon, Atherosclerosis in the younger patient, The American Journal of Surgery. août, vol.154, issue.2, p.2259, 1987.

P. J. Levy, M. F. Gonzalez, C. A. Hornung, W. W. Chang, J. L. Haynes et al., A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis, Journal of VascularSurgery, vol.23, issue.1, pp.36-45, 1996.

P. C. Pairolero, Lower limb ischemia in young adults: Prognostic implications, vol.1, p.6, 1984.

J. B. Richard and F. Beck, Tendances de long terme des consommations de tabac et d'alcool en

. France, Bull Epidémiol Hebd, issue.7-8, pp.126-159, 2016.

S. S. Mahmood, D. Levy, R. S. Vasan, and T. J. Wang, The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective, The Lancet. mars, vol.383, issue.9921, pp.999-1008, 2014.

R. J. Valentine, H. S. Kaplan, R. Green, D. W. Jacobsen, S. I. Myers et al., Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: A prospective, controlled analysis, Journal of Vascular Surgery. janv, vol.23, issue.1, p.5363, 1996.

M. Sandkamp, H. Funke, H. Schulte, E. Kohler, and G. Assmann, Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age, Clin Chem, vol.36, pp.20-23, 1990.

M. Nagayama, Y. Shinohara, and T. Nagayama, Lipoprotein (a) and ischemic cerebrovascular disease in young adults, Stroke, vol.25, pp.74-82, 1994.

C. S. Berwanger, J. Y. Jeremy, and G. Stansby, Homocysteine and vascular disease, Br J Surg. juin, vol.82, issue.6, p.72631, 1995.

W. Renner, H. Köppel, M. Brodmann, E. Pabst, K. Schallmoser et al., Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease

, Thromb Haemost, vol.83, pp.20-22, 2000.

L. Hello, C. Blacher, J. Conard, J. Piette, J. Constans et al., Thrombophilies et artériopathie oblitérante des membres inférieurs, Journal des Maladies Vasculaires. sept, vol.33, issue.3, pp.126-162, 2008.

R. J. Kim and R. C. Becker, Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reduc-tase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies, Am Heart J, vol.146, pp.948-57, 2003.

S. Miyakis, M. D. Lockshin, T. Atsumi, D. W. Branch, R. L. Brey et al., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost. févr, vol.4, issue.2, pp.295-306, 2006.

P. P. Cacoub, M. Abola, I. Baumgartner, D. L. Bhatt, M. A. Creager et al.,

, Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry, Atherosclerosis. juin, vol.204, issue.2, pp.86-92, 2009.

P. S. Olsen, J. Gustafsen, L. Rasmussen, and J. E. Lorentzen, Long-term results after arterial surgery for arteriosclerosis of the lower limbs in young adults, Eur J Vasc Surg, vol.2, pp.15-23, 1988.

P. Cacoub, A. Hirsch, M. Abola, I. Baumgartner, M. Creager et al.,

, Artériopathie périphérique des membres inférieurs (AOMI) : suivi à deux ans du registre REACH, Journal des Maladies Vasculaires. sept, vol.33, p.81, 2008.

S. Jaiswal, P. Fontanillas, J. Flannick, A. Manning, P. V. Grauman et al., Age-related clonal hematopoiesis associated with adverse outcomes, N Engl J Med, vol.371, issue.26, pp.2488-98, 2014.

P. M. Ridker, J. G. Macfadyen, T. Thuren, B. M. Everett, P. Libby et al., Effect of interleukin-1? inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial, Lancet, vol.390, p.1833, 2017.

C. Chu-d'amiens,